Outset Medical has raised $76.5 million in a series C round led by T. Rowe Price Associates. In addition to new investor T. Rowe Price Associates, existing investors Fidelity Management & Research ...
SAN JOSE, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) ("Outset"), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in ...
This article first appeared on GuruFocus. Outset Medical Inc (NASDAQ:OM) is set to release its Q1 2026 earnings on May 7, 2026. The consensus estimate for Q1 2026 revenue is $28.90 million, and the ...
Outset said that it has resumed distribution of TabloCart with prefiltration and has product available to ship to customers in the United States. “With the FDA’s clearance of TabloCart with ...
Zacks Investment Research on MSN
Outset Medical (OM) surges 25.6%: Is this an indication of further gains?
Outset Medical, Inc. OM shares soared 25.6% in the last trading session to close at $5.05. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...
Warburg Pincus’ decade-long investment in a business looking to redefine kidney dialysis care is proving a home run for the private equity firm. Following Outset Medical’s $242 million IPO on Tuesday, ...
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, a commercial-stage company delivering first-of-its-kind technology into the growing global dialysis market, today announced the appointment of two ...
Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener The latest update ...
Hosted on MSN
Why Did Outset Medical Stock Tumble Today?
・For Q3, Outset Medical’s adjusted net loss came in at $0.69 per share, higher than an estimated loss of $0.66 per share. ・Several analysts subsequently slashed price targets on Tuesday. ・RBC Capital ...
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, a commercial-stage company delivering first-of-its-kind technology into the growing global dialysis market, today announced the appointment of ...
Medical device companies can't market or ship their products unless the U.S. Food and Drug Administration (FDA) says they can. So when Outset Medical (NASDAQ: OM) suspended shipments of its Tablo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results